Nanovery Team2 (1)

An innovative start up aiming to change the way some of the most devastating diseases are diagnosed has gained £475k of investment.

Nanovery is developing nanorobots that will improve diagnosis of diseases like cancer by delivering clinically relevant information faster and at a lower cost than currently used methods.   

The North East Innovation Fund, supported by the European Regional Development Fund and managed by Northstar Ventures has invested £250,000, with additional funding coming from SFC, Early Market, and other Angel investors.  

The company, which has attracted world-class scientists to join its laboratories in the North East will use the funding to advance its nanorobotic technology and accelerate the development of its diagnostic platform. It will also help develop more meaningful engagement with industry and research institutions, such as Newcastle Centre for Cancer. 

Nanovery CEO Dr Jurek Kozyra says, “While the whole world is focused on fighting Covid-19 and routine medical check-ups are at an all-time low, more people than ever before suffer from an undiagnosed disease.  

"This poses a serious threat to healthcare systems worldwide and will have a huge impact on future patient care. We are sitting on a ticking time bomb, and something has to be done about it." 

Kasia Zmarzly, co-founder and Head of Business Development adds "At Nanovery, we are spearheading this next phase of recovery. Doctors are our partners, and they need all the assistance we can give them to be sure we get the right diagnosis." 

Northstar Ventures Investment Manager Khadija Ashfaq said, “We’re really pleased to be supporting this innovative start up, developing a game changing product that will lead to more rapid, affordable and personalised diagnostic tests. It is another great example of the expertise and ambition that is prevalent in the region, and also shows how businesses are able to leverage the expertise of the universities here." 

Key Takeaways: 

  • Nanovery is working to improve the diagnosis of some of the worlds most devastating diseases with nanorobotic technology.
  • The company has recently raised £475k in investment, which will be used to accelerate its diagnostic platform. 

The Go Further Investment Index is an opportunity to engage, showcase and celebrate progressive businesses who are pushing through and achieving their aspirations through access to investment, impactful collaborations, and the foresight to inform and respond to the changing world around them.

It is open to Northern Powerhouse and Scotland-based businesses of all sizes and from all sectors, but we are particularly interested in businesses operating within bio-science, health tech, clean energy, decarbonisation, circular economy, data and digitisation, space and satellite, tech, AI and advanced manufacturing.

For more info visit

Ashleigh Smith
Article by Ashleigh Smith
Share Article